Genus plc
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as techni… Read more
Market Cap & Net Worth: Genus plc (GENSY)
Genus plc (PINK:GENSY) has a market capitalization of $1.76 Billion ($1.76 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #5380 globally and #3186 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genus plc's stock price $26.54 by its total outstanding shares 66413228 (66.41 Million).
Genus plc Market Cap History: 2024 to 2025
Genus plc's market capitalization history from 2024 to 2025. Data shows growth from $1.76 Billion to $1.76 Billion (0.00% CAGR).
Genus plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genus plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.62x
Genus plc's market cap is 2.62 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
91.33x
Genus plc's market cap is 91.33 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $1.76 Billion | $668.80 Million | $7.90 Million | 2.64x | 223.11x |
| 2025 | $1.76 Billion | $672.80 Million | $19.30 Million | 2.62x | 91.33x |
Competitor Companies of GENSY by Market Capitalization
Companies near Genus plc in the global market cap rankings as of March 18, 2026.
Key companies related to Genus plc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Genus plc Historical Marketcap From 2024 to 2025
Between 2024 and today, Genus plc's market cap moved from $1.76 Billion to $ 1.76 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.76 Billion | 0.00% |
| 2024 | $1.76 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Genus plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.76 Billion USD |
| MoneyControl | $1.76 Billion USD |
| MarketWatch | $1.76 Billion USD |
| marketcap.company | $1.76 Billion USD |
| Reuters | $1.76 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.